????8. 強(qiáng)生

????? 2013年研發(fā)支出：82億美元

????? 占收入的百分比：11.5%

????長期以來,，研發(fā)投資一直讓這家美國醫(yī)療保健公司引以為豪,。在過去五年中，強(qiáng)生也一直是制藥行業(yè)研發(fā)投入最多的企業(yè)之一,。這些投資已經(jīng)帶來了高額回報(bào)——2009年以來,，強(qiáng)生的制藥業(yè)務(wù)已推出14種新藥。強(qiáng)生表示,，該公司計(jì)劃在2013-2017年推出十多種新藥和25種延伸產(chǎn)品。

????8. Johnson & Johnson

????? R&D spending in 2013: $8.2 billion

????? As a percentage of revenue: 11.5%

????The American health care company has long prided itself on investing in R&D and for the past five years has consistently been among the top spenders in the pharma industry. That investment has paid off big, with the pharmaceutical business launching 14 new compounds since 2009. J&J says it plans to file more than 10 new drugs and 25 line extensions between 2013 and 2017.